Kalbe Farma Tbk. PT (LCLA)
Market Closed
12 Jun, 20:00
XMUN 
€
0. 04
+0
+2.8571%
€
4.61B Market Cap
- P/E Ratio
0.01% Div Yield
0 Volume
0 Eps
€ 0.04
Previous Close Want to track LCLA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kalbe Farma Tbk. PT (LCLA) Statistics
Valuation metrics
Market Cap 4.61B
Enterprise value -4.16T
Trailing P/E (ttm) 0
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -0.13
Enterprise Value/EBITDA -0.9
Overview
Shares outstanding 45.39B
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 20K
Average volume (90 days) 6.67K
Price summary
52-Week low 0.03
52-Week high 0.08
Beta -
50-Day moving average 0.06
200-Day moving average 0.06
Dividends and splits
Forward annual dividend rate 0.01
Forward annual dividend yield 0.1489%
Trailing annual dividend rate 0
Trailing annual dividend yield 0.0372%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 5:1
Last split Date 8 Oct 2012
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.4%
Operating margin 0.13%
Operational effectiveness
Return on assets 0.11%
Return on equity 0.13%
Income Statement
Revenue (ttm) 32.63T
Revenue per share (ttm) 706.43
Quarterly revenue growth (yoy) -0.07%
Gross profit (ttm) 12.96T
EBITDA 4.88T
Net income to common (ttm) 3.24T
Diluted EPS (ttm) 70.16
Quarterly earnings growth (yoy) 0.03%
Balance Sheet
Total cash (mrq) 2.08T
Total cash per share (mrq) -
Total debt (mrq) 779.98B
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 3.78%
Book value per share (mrq) -
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) 3.24T
